Baillie Gifford Halozyme Therapeutics Inc.

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$36.7

Avg closing price
Price range
Baillie Gifford Portfolio Stock Details (HALO)

8 Baillie Gifford Halozyme Therapeutics Trades

The first Halozyme Therapeutics trade was made in Q4 2020. Since then Baillie Gifford bought shares two more times and sold shares on five occasions. The investor completely sold their stake between Q3 2022 and Q1 2023.

Avg closing price
Price range
Sold -763 shares Q1 2023
Avg closing price $46.91
Price range $32.86 - $55.70
Sold 6.4% shares (-52 shares) Q3 2022
Avg closing price $44.20
Price range $38.53 - $51.78
Increased shares by 4.6% (+36 shares) Q2 2022
Avg closing price $43.25
Price range $37.35 - $48.30
Sold 11.5% shares (-101 shares) Q4 2021
Avg closing price $37.33
Price range $31.82 - $40.75
Sold 8.5% shares (-82 shares) Q3 2021
Avg closing price $41.81
Price range $38.47 - $46.42
Sold 4.4% shares (-44 shares) Q2 2021
Avg closing price $44.26
Price range $38.84 - $51.31
Increased shares by 5.5% (+52 shares) Q1 2021
Avg closing price $45.65
Price range $39.51 - $51.45
New holding (+954 shares) Q4 2020
Avg closing price $35.95
Price range $25.81 - $43.62
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.